A report by the country’s audit body on the statutory health insurance system has denounced the lack of rigour in the way prices are set for purchases of drugs from pharmaceutical companies.
The report, published on 8 September, comes as the government tries to curb its heath spending.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.